vs

Side-by-side financial comparison of Federal Realty Investment Trust (FRT) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

Federal Realty Investment Trust is the larger business by last-quarter revenue ($336.0M vs $197.9M, roughly 1.7× REPLIGEN CORP). Federal Realty Investment Trust runs the higher net margin — 38.6% vs 6.7%, a 31.9% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 8.7%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 6.5%).

Federal Realty Investment Trust is a real estate investment trust that invests in shopping centers in the Northeastern United States, the Mid-Atlantic states, California, and South Florida.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

FRT vs RGEN — Head-to-Head

Bigger by revenue
FRT
FRT
1.7× larger
FRT
$336.0M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+4.9% gap
RGEN
13.6%
8.7%
FRT
Higher net margin
FRT
FRT
31.9% more per $
FRT
38.6%
6.7%
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
6.5%
FRT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FRT
FRT
RGEN
RGEN
Revenue
$336.0M
$197.9M
Net Profit
$129.7M
$13.3M
Gross Margin
52.5%
Operating Margin
53.8%
9.0%
Net Margin
38.6%
6.7%
Revenue YoY
8.7%
13.6%
Net Profit YoY
103.5%
143.9%
EPS (diluted)
$1.49
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRT
FRT
RGEN
RGEN
Q1 26
$336.0M
Q4 25
$336.0M
$197.9M
Q3 25
$322.3M
$188.8M
Q2 25
$311.5M
$182.4M
Q1 25
$309.2M
$169.2M
Q4 24
$311.4M
$174.1M
Q3 24
$303.6M
$154.9M
Q2 24
$296.1M
$154.1M
Net Profit
FRT
FRT
RGEN
RGEN
Q1 26
$129.7M
Q4 25
$129.7M
$13.3M
Q3 25
$61.6M
$14.9M
Q2 25
$155.9M
$14.9M
Q1 25
$63.8M
$5.8M
Q4 24
$65.5M
$-30.3M
Q3 24
$61.0M
$-654.0K
Q2 24
$112.0M
$3.3M
Gross Margin
FRT
FRT
RGEN
RGEN
Q1 26
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Operating Margin
FRT
FRT
RGEN
RGEN
Q1 26
53.8%
Q4 25
53.8%
9.0%
Q3 25
34.3%
8.9%
Q2 25
65.1%
7.6%
Q1 25
35.0%
3.9%
Q4 24
35.1%
-17.7%
Q3 24
34.9%
-5.1%
Q2 24
53.0%
1.0%
Net Margin
FRT
FRT
RGEN
RGEN
Q1 26
38.6%
Q4 25
38.6%
6.7%
Q3 25
19.1%
7.9%
Q2 25
50.0%
8.2%
Q1 25
20.6%
3.4%
Q4 24
21.0%
-17.4%
Q3 24
20.1%
-0.4%
Q2 24
37.8%
2.2%
EPS (diluted)
FRT
FRT
RGEN
RGEN
Q1 26
$1.49
Q4 25
$1.49
$0.24
Q3 25
$0.69
$0.26
Q2 25
$1.78
$0.26
Q1 25
$0.72
$0.10
Q4 24
$0.74
$-0.55
Q3 24
$0.70
$-0.01
Q2 24
$1.32
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRT
FRT
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$107.4M
$767.6M
Total DebtLower is stronger
$5.0B
$542.2M
Stockholders' EquityBook value
$3.2B
$2.1B
Total Assets
$9.1B
$2.9B
Debt / EquityLower = less leverage
1.53×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRT
FRT
RGEN
RGEN
Q1 26
$107.4M
Q4 25
$107.4M
$767.6M
Q3 25
$111.3M
$748.7M
Q2 25
$177.0M
$708.9M
Q1 25
$109.2M
$697.2M
Q4 24
$123.4M
$757.4M
Q3 24
$97.0M
$784.0M
Q2 24
$103.2M
$809.1M
Total Debt
FRT
FRT
RGEN
RGEN
Q1 26
$5.0B
Q4 25
$5.0B
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$4.5B
$525.6M
Q3 24
Q2 24
Stockholders' Equity
FRT
FRT
RGEN
RGEN
Q1 26
$3.2B
Q4 25
$3.2B
$2.1B
Q3 25
$3.2B
$2.1B
Q2 25
$3.2B
$2.1B
Q1 25
$3.2B
$2.0B
Q4 24
$3.2B
$2.0B
Q3 24
$3.1B
$2.0B
Q2 24
$3.0B
$2.0B
Total Assets
FRT
FRT
RGEN
RGEN
Q1 26
$9.1B
Q4 25
$9.1B
$2.9B
Q3 25
$8.9B
$2.9B
Q2 25
$8.6B
$2.9B
Q1 25
$8.6B
$2.9B
Q4 24
$8.5B
$2.8B
Q3 24
$8.5B
$2.8B
Q2 24
$8.4B
$2.9B
Debt / Equity
FRT
FRT
RGEN
RGEN
Q1 26
1.53×
Q4 25
1.53×
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
1.42×
0.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRT
FRT
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRT
FRT
RGEN
RGEN
Q1 26
Q4 25
$622.4M
$25.7M
Q3 25
$147.8M
$48.1M
Q2 25
$150.7M
$28.6M
Q1 25
$179.0M
$15.0M
Q4 24
$574.6M
$39.2M
Q3 24
$144.1M
$49.3M
Q2 24
$169.7M
$42.2M
Free Cash Flow
FRT
FRT
RGEN
RGEN
Q1 26
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
FCF Margin
FRT
FRT
RGEN
RGEN
Q1 26
Q4 25
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Capex Intensity
FRT
FRT
RGEN
RGEN
Q1 26
Q4 25
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Cash Conversion
FRT
FRT
RGEN
RGEN
Q1 26
Q4 25
4.80×
1.93×
Q3 25
2.40×
3.23×
Q2 25
0.97×
1.92×
Q1 25
2.81×
2.57×
Q4 24
8.77×
Q3 24
2.36×
Q2 24
1.52×
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons